<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41410">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02567292</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00080481</org_study_id>
    <nct_id>NCT02567292</nct_id>
  </id_info>
  <brief_title>Breast Milk and Congenital Gastrointestinal Disorders</brief_title>
  <official_title>Effects of an All Breast Milk Diet on Enteral Feeding Outcomes of Neonates With Congenital Gastrointestinal Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to identify whether an all breast milk (BM) diet would improve outcomes in
      neonates with congenital gastrointestinal disorders (CGD) by facilitating an earlier
      transition off of parenteral nutrition (PN).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Post initial feeding (Up to ten days)</time_frame>
    <description>The length of hospital stay described as the number of days spent in the hospital after the initial breast milk feeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to full enteral feeding</measure>
    <time_frame>Post initial feeding (Up to ten days)</time_frame>
    <description>The number of days to achieve full enteral feeding after the initial breast milk feeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of parenteral nutrition</measure>
    <time_frame>Post initial feeding (Up to ten days)</time_frame>
    <description>The total number of days parenteral nutrition is required.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in bilirubin levels</measure>
    <time_frame>Post initial feeding (Up to ten days)</time_frame>
    <description>The difference in average bilirubin level will be compared between the non-breast milk diet (retrospective control group) and the breast milk diet group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of sepsis episodes</measure>
    <time_frame>Post initial feeding (Up to ten days)</time_frame>
    <description>The number of sepsis episodes will be compared between the non-breast milk diet (retrospective control group) and the breast milk diet group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death rate</measure>
    <time_frame>Post initial feeding (Up to ten days)</time_frame>
    <description>The number of deaths between participants who receive breast milk only diets as compared to the non-breast milk diet (retrospective control group while in the neonatal intensive care unit (NICU).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Congenital Gastrointestinal Disorders</condition>
  <arm_group>
    <arm_group_label>Retrospective Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Approximately 45 patients with congenital gastrointestinal disorders who were treated in the neonatal intensive care unit (NICU) at Children's Healthcare of Atlanta-Egleston from 2012 to 2015, who had non-breast milk (BM) diets will be identified as retrospective controls using the electronic medical records system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective Breast Milk Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Approximately 45 participants with congenital gastrointestinal disorders who are admitted to the neonatal intensive care unit (NICU) will have an exclusively breast milk (BM) diet, fortified with Prolacta if required.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Breast Milk</intervention_name>
    <description>Participants will receive breast milk (fortified with Prolacta if required per doctor's discretion) for regular feedings while in the neonatal intensive care unit (NICU).</description>
    <arm_group_label>Prospective Breast Milk Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neonates admitted to the Egleston Neonatal intensive care unit (NICU) who have never
             been fed

          -  Congenital gastrointestinal abnormalities such as gastroschisis, bowel atresias,
             malrotation, omphalocele, or meconium ileus

        Exclusion Criteria:

          -  Previous feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan Durham, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Megan Durham, MD</last_name>
    <phone>404-785-8787</phone>
    <email>megan.durham@emory.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta-Egleston</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Durham, MD</last_name>
      <phone>404-727-3779</phone>
      <email>megan.durham@emory.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 12, 2016</lastchanged_date>
  <firstreceived_date>October 1, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Megan Durham</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Digestive Disease and Disorders</keyword>
  <keyword>Neonatal</keyword>
  <keyword>Pediatric Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
